What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
Identifieur interne : 003E89 ( Main/Exploration ); précédent : 003E88; suivant : 003E90What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
Auteurs : Stephen J. Kish [Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-11.
English descriptors
- KwdEn :
- Brain (blood supply), Brain (drug effects), Brain (physiopathology), Carrier Proteins (drug effects), Hallucinogens (adverse effects), Humans, Membrane Glycoproteins (drug effects), Membrane Transport Proteins, N-Methyl-3,4-methylenedioxyamphetamine (adverse effects), Nerve Tissue Proteins, Parkinson Disease, Secondary (chemically induced), Parkinson Disease, Secondary (diagnosis), Parkinson Disease, Secondary (physiopathology), Receptors, Dopamine (drug effects), Serotonin Plasma Membrane Transport Proteins, Tomography, Emission-Computed, Tomography, Emission-Computed, Single-Photon.
- MESH :
- chemical , adverse effects : Hallucinogens, N-Methyl-3,4-methylenedioxyamphetamine.
- chemical , drug effects : Carrier Proteins, Membrane Glycoproteins, Receptors, Dopamine.
- blood supply : Brain.
- chemically induced : Parkinson Disease, Secondary.
- diagnosis : Parkinson Disease, Secondary.
- drug effects : Brain.
- physiopathology : Brain, Parkinson Disease, Secondary.
- Humans, Membrane Transport Proteins, Nerve Tissue Proteins, Serotonin Plasma Membrane Transport Proteins, Tomography, Emission-Computed, Tomography, Emission-Computed, Single-Photon.
Url:
DOI: 10.1002/mds.10643
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003766
- to stream Istex, to step Curation: 003766
- to stream Istex, to step Checkpoint: 002818
- to stream PubMed, to step Corpus: 003649
- to stream PubMed, to step Curation: 003649
- to stream PubMed, to step Checkpoint: 003585
- to stream Ncbi, to step Merge: 000C15
- to stream Ncbi, to step Curation: 000C15
- to stream Ncbi, to step Checkpoint: 000C15
- to stream Main, to step Merge: 005B11
- to stream Main, to step Curation: 003E89
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?</title><author><name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J." last="Kish">Stephen J. Kish</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A134010B6F1E58FBC5441C9DBB779BD2B67351FA</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10643</idno><idno type="url">https://api.istex.fr/document/A134010B6F1E58FBC5441C9DBB779BD2B67351FA/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003766</idno><idno type="wicri:Area/Istex/Curation">003766</idno><idno type="wicri:Area/Istex/Checkpoint">002818</idno><idno type="wicri:doubleKey">0885-3185:2003:Kish S:what:is:the</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:14639660</idno><idno type="wicri:Area/PubMed/Corpus">003649</idno><idno type="wicri:Area/PubMed/Curation">003649</idno><idno type="wicri:Area/PubMed/Checkpoint">003585</idno><idno type="wicri:Area/Ncbi/Merge">000C15</idno><idno type="wicri:Area/Ncbi/Curation">000C15</idno><idno type="wicri:Area/Ncbi/Checkpoint">000C15</idno><idno type="wicri:doubleKey">0885-3185:2003:Kish S:what:is:the</idno><idno type="wicri:Area/Main/Merge">005B11</idno><idno type="wicri:Area/Main/Curation">003E89</idno><idno type="wicri:Area/Main/Exploration">003E89</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?</title><author><name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J." last="Kish">Stephen J. Kish</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Human Neurochemical Pathology Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-11">2003-11</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1219">1219</biblScope><biblScope unit="page" to="1223">1223</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A134010B6F1E58FBC5441C9DBB779BD2B67351FA</idno><idno type="DOI">10.1002/mds.10643</idno><idno type="ArticleID">MDS10643</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brain (blood supply)</term><term>Brain (drug effects)</term><term>Brain (physiopathology)</term><term>Carrier Proteins (drug effects)</term><term>Hallucinogens (adverse effects)</term><term>Humans</term><term>Membrane Glycoproteins (drug effects)</term><term>Membrane Transport Proteins</term><term>N-Methyl-3,4-methylenedioxyamphetamine (adverse effects)</term><term>Nerve Tissue Proteins</term><term>Parkinson Disease, Secondary (chemically induced)</term><term>Parkinson Disease, Secondary (diagnosis)</term><term>Parkinson Disease, Secondary (physiopathology)</term><term>Receptors, Dopamine (drug effects)</term><term>Serotonin Plasma Membrane Transport Proteins</term><term>Tomography, Emission-Computed</term><term>Tomography, Emission-Computed, Single-Photon</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Hallucinogens</term><term>N-Methyl-3,4-methylenedioxyamphetamine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Carrier Proteins</term><term>Membrane Glycoproteins</term><term>Receptors, Dopamine</term></keywords><keywords scheme="MESH" qualifier="blood supply" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Membrane Transport Proteins</term><term>Nerve Tissue Proteins</term><term>Serotonin Plasma Membrane Transport Proteins</term><term>Tomography, Emission-Computed</term><term>Tomography, Emission-Computed, Single-Photon</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J." last="Kish">Stephen J. Kish</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003E89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A134010B6F1E58FBC5441C9DBB779BD2B67351FA
|texte= What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
}}
| This area was generated with Dilib version V0.6.23. |  |